Strona 14 - Najlepsi onkolodzy – TOP 653 lekarzy

Dr Klaus Novak wprowadził w Austrii śródoperacyjne monitorowanie motorycznych potencjałów wywołanych – technikę zwiększającą precyzję w neurochirurgii. Pracuje w prywatnym szpitalu Döbling.

• Ponad 20 lat doświadczenia w neurochirurgii i onkologii
• Specjalizuje się w guzach mózgu i chirurgii kręgosłupa
• Szkolił się na arenie międzynarodowej, w tym prowadził badania w Beth Israel Hospital
• Aktywny członek interdyscyplinarnej Rady ds. Zaburzeń Ruchowych na MedUni Vienna
• Biegle włada kilkoma językami, w tym angielskim i niemieckim

Prof. dr hab. n. med. Heinz Gisslinger był pionierem terapii interferonem w nowotworach mieloproliferacyjnych i kieruje jednym z najlepszych w Europie programów badawczych w zakresie tych schorzeń.

• Ponad 40 lat specjalizacji w MPN, takich jak czerwienica prawdziwa i nadpłytkowość samoistna
• Założyciel Wiedeńskiego Laboratorium Nowotworów Mieloproliferacyjnych
• Dyrektor programu badań nad MPN z bogatym doświadczeniem w badaniach klinicznych
• Leczy wszystkie nowotwory hematologiczne, w tym przewlekłą białaczkę szpikową i szpiczaka

Dr. Hisham Khalifa is a Consultant Surgical Oncologist. He assesses, diagnoses, and operates on gynecological cancers, including ovarian, uterine, cervical, vaginal, and vulval cancers. He performs both minimally invasive (laparoscopic) and open surgery.

Career milestones: Resident and faculty member at the National Cancer Institute, Cairo University (2001–2014). Assistant Professor at AlFaisal University and Assistant Consultant at King Faisal Hospital and Research Center (KFSHRC), Riyadh (2014–2019). Consultant at the NCI, Cairo (2019–present); Director of the Professional Diploma in Gyne-Onco Surgery. Consultant at the Oncology Pediatric Hospital–Alexandria University and Shefa Al Orman Comprehensive Cancer Center, Luxor (2020–present).

Credentials: MBBCh (1999); Master’s in General Surgery (2004); Doctorate in Surgical Oncology (2008); Fellowship of the European Board of Surgery (FEBS, UEMS). Memberships: FACS; SSO; ESSO; ECS; EGSSO.

Dr Karatas specjalizuje się w złożonych operacjach głowy i szyi, odbył międzynarodowe szkolenia w czołowych instytucjach, takich jak Szkoła Medyczna w Hanowerze i Uniwersytet Stanowy Ohio.

• Przeszkolony w zakresie zaawansowanych technik endoskopowych w chirurgii podstawy czaszki
• Specjalizuje się w tyreoidektomii i złożonych przypadkach tarczycy
• Członek Amerykańskiej Akademii Otolaryngologii – Chirurgii Głowy i Szyi
• Ekspert w dziedzinie implantów ślimakowych i operacji związanych ze słuchem

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.

He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.

His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.

He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.

Absolwent z wyróżnieniem Uniwersytetu Hacettepe, specjalizujący się w żywieniu onkologicznym, z badaniami nad leczeniem chorób przewlekłych.

• Prowadził badania nad związkiem między insulinoopornością a otyłością
• Odbył staż w Szpitalu Onkologicznym Uniwersytetu Hacettepe
• Ukończył specjalistyczne kursy z zakresu żywienia bariatrycznego
• Pracuje z różnymi pacjentami onkologicznymi, w tym z przypadkami raka trzustki i wątroby
• Biegle posługuje się językiem angielskim w konsultacjach międzynarodowych

Dr. Eytan Aharon Ben‑Ami, MD, is a Senior Physician in the Sarcoma and Bone Oncology Service at Sheba Medical Center. He heads the Oncology Division and the Early-Phase Clinical Trials Unit. He founded the Sheba Clinical Research Organization. He is an academic affiliate at Tel Aviv University.

He specializes in sarcomas and primary bone tumors, including soft tissue sarcoma, liposarcoma, leiomyosarcoma, and osteosarcoma. He leads Phase I trials in targeted therapy and immunotherapy. He designs personalized treatment plans for rare cancers. He also develops patient-centered programs, including pilots in advanced immunotherapy delivery.

He completed a fellowship in Sarcoma and Bone Oncology at the Dana-Farber Cancer Institute/Harvard Cancer Center. He has authored more than 40 publications on early detection, molecular and viral mechanisms, and new cancer therapies.

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Professor Dr. Kurt Rasche is a German pulmonologist with more than 40 years of clinical experience. He is Chief of Pulmonology at Helios University Hospital Wuppertal. He leads the departments of pulmonology, sleep medicine, and ventilation therapy. He also heads the certified Lung Cancer Center.

He is certified in internal medicine, pulmonology, allergology, sleep medicine, and intensive care. His clinical work focuses on diagnosing and treating chronic lung diseases, lung cancer, and sleep-related breathing disorders. He works closely with specialists from other fields to provide coordinated care.

Dr. Rafał Marszałek is a general, oncologic, and bariatric surgeon. He specializes in minimally invasive and laparoscopic techniques. He leads the General Surgery Department at the Hospital in Legionowo, affiliated with the Military Medical Institute. He has many years of clinical experience from leading centers in Warsaw and the region.

As department head, he applies current treatment standards and advances modern surgical practice. The unit performs a high volume of procedures each year and provides full perioperative care. His key focus is bariatric surgery. He manages patient qualification, selects tailored laparoscopic methods, and provides postoperative monitoring. The goal is durable weight loss and reduced obesity‑related risk. His work also includes hernia repair, gallbladder surgery, thyroid and parathyroid surgery, breast surgery, and oncologic procedures.

Specjalizuje się w złożonych operacjach raka trzustki i dróg żółciowych w szpitalach Büyük Anadolu – łączy wiedzę onkologiczną z technikami chirurgii metabolicznej.

• Biegły w małoinwazyjnych procedurach nowotworów układu pokarmowego
• Wykonuje zaawansowane operacje raka piersi i tarczycy
• Doświadczony w bariatrycznych zabiegach metabolicznych w schorzeniach powiązanych
• Pracuje w multidyscyplinarnym zespole zapewniającym kompleksową opiekę onkologiczną

Dr. Son Dong Wan, MD, PhD, is the Chief of Urology at Naeun Hospital. He specializes in urologic oncology, urinary incontinence, sexual dysfunction, and laser prostate surgery. He performs robotic and laparoscopic surgery for cancers of the prostate, bladder, ureter, and kidney. He also treats ureteropelvic junction (UPJ) obstruction.

He earned his PhD from Pusan National University. He completed his internship and residency at Pusan National University Hospital. He is a former Chief at Wallace Memorial Baptist Hospital. He served as a Professor at the Catholic University College of Medicine. He was a Clinical Fellow at Seoul National University Bundang Hospital. He was a Visiting Professor at the University of California, San Diego (UCSD). He completed training in urinary incontinence surgery at the University of Liège.

Awards include the Excellent Paper Award (2007) and the Academic Achievement Award (2014) from the Korean Continence Society. He also received the Best Poster Award from the European Association of Urology (2013).

Dr. Lucía González Cortijo is a medical oncologist with more than 20 years of experience. She has led the Medical Oncology Department at Hospital Universitario Quirónsalud Madrid since 2020. Her focus areas include breast and gynecologic cancers. She also works in precision oncology, targeted therapies, and immunotherapy.

She has been Principal Investigator in more than 20 Phase II–III clinical trials. She has also served as sub-investigator in over 50 international trials. She previously worked at Quirónsalud Madrid from 2009 to 2020. Before that, she was at MD Anderson Cancer Center Madrid from 2002 to 2009.

She holds an MD and a PhD (cum laude) from the Autonomous University of Madrid. She completed her Medical Oncology specialty training at Hospital 12 de Octubre. She also earned a Master’s in Molecular Oncology. She is a member of SEOM, ESMO, ASCO, and GEICAM. She is a university lecturer.

Assoc. Prof. Dr. Mehmet Salih İyikesici is a medical oncologist. He provides personalized care for breast, lung, and gastrointestinal cancers. He combines metabolically supported therapies with chemotherapy. His interests include the ketogenic diet in cancer care, hyperthermia, and hyperbaric oxygen therapy.

He has conducted and contributed to national and international scientific studies. Selected national peer-reviewed publications include Metabolic Supported Chemotherapy in Rectal Cancer (2020), NSCLC Patient Outcomes – Marmara University (2004), and Early-Stage Breast Cancer Outcomes (2004).

Dr. Zohar Dotan is Head of the Urology Department at Sheba Medical Center. He is a leading uro-oncologist and a pioneer of robotic and laparoscopic urologic surgery in Israel.

He has authored more than 50 scientific publications. He is a regular speaker at international conferences. He has received awards from the American Association of Clinical Surgery, including recognition for research in prostate cancer treatment.

Leadership and credentials: Head of the Israeli Uro-Oncology Society. Assistant Professor at Tel Aviv University. Member of the Israeli, American, and European Urological Associations. Training: MD from Tel Aviv University and a PhD in Genetics. Urology residency at Sheba Medical Center. Fellowship in uro-oncology and laparoscopic surgery at Memorial Sloan Kettering, New York.

43 lata oddanego doświadczenia w onkologii – dr Wan Zsiannan wnosi głęboką wiedzę specjalistyczną w przypadki raka wątroby w Fuda Cancer Hospital.

• Specjalizuje się w onkologii, ze szczególnym uwzględnieniem raka wątroby
• Pracuje w Fuda Cancer Hospital – wyspecjalizowanym ośrodku leczenia nowotworów
• Bogate doświadczenie w diagnozowaniu i prowadzeniu złożonych przypadków onkologicznych

Dr Do Hyun Nam jest czołowym neurochirurgiem specjalizującym się w endoskopowych operacjach mózgu w Samsung Medical Center – wiodącym szpitalu neurochirurgicznym w Korei Południowej.

• Leczy guzy mózgu zarówno u dzieci, jak i u dorosłych
• Ekspert w małoinwazyjnych technikach endoskopowych
• Doświadczony w radiochirurgii w precyzyjnym celowaniu w guzy
• Zajmuje się zarówno nowotworami łagodnymi, jak i złośliwymi